Cargando…
Down-regulation of osteopontin attenuates breast tumour progression in vivo
Development of breast tumour malignancies results in enhanced expression of various oncogenic molecules. Elevated expression of osteopontin (OPN) in higher grades of breast carcinoma correlates with enhanced expressions of several oncogenic molecules (urokinase-type plasminogen activator [uPA], matr...
Autores principales: | Chakraborty, Goutam, Jain, Shalini, Patil, Tushar V, Kundu, Gopal C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514110/ https://www.ncbi.nlm.nih.gov/pubmed/18266970 http://dx.doi.org/10.1111/j.1582-4934.2008.00263.x |
Ejemplares similares
-
Functional Characterization of Stromal Osteopontin in Melanoma Progression and Metastasis
por: Kumar, Santosh, et al.
Publicado: (2013) -
Role of osteopontin in tumour progression
por: Rittling, S R, et al.
Publicado: (2004) -
Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model
por: Chakraborty, Goutam, et al.
Publicado: (2012) -
The role of osteopontin in the progression of solid organ tumour
por: Zhao, Hailin, et al.
Publicado: (2018) -
Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells
por: Sharma, Priyanka, et al.
Publicado: (2010)